TI - Overcoming Hormone Resistance in Breast Cancer Cell Lines: The Impact of Combined Treatment with Sorafenib and Palbociclib on Cell Survival and Proliferation Pathways
PT - Journal Article
DP - 2024
TA - EJMI
PG - 13-20
VI - 8
IP - 1
AID - 2023.14963 [doi]
4100 - https://dx.doi.org/10.14744/ejmi.2023.14963
SO - EURASIAN JOURNAL OF MEDICIAL INVESTIGATION,2024 8(1): 13